TY  - GEN
AU  - Kissling, Esther
AU  - Hooiveld, Mariëtte
AU  - Sandonis-Martin, Virginia
AU  - Martínez-Baz, Iván
AU  - William, Naoma
AU  - Vilcu, Ana-Maria
AU  - Mazagatos, Clara
AU  - Domegan, Lisa
AU  - de Lusignan, Simon
AU  - Meijer, Adam
AU  - Machado, Ausenda
AU  - Brytting, Mia
AU  - Casado, Itziar
AU  - Murray, Josephine-L K
AU  - Belhillil, Sylvie
AU  - Larrauri, Amparo
AU  - O'Donnell, Joan
AU  - Tsang, Ruby
AU  - de Lange, Marit
AU  - Rodrigues, Ana Paula
AU  - Riess, Maximilian
AU  - Castilla Catalán, Jesús
AU  - Hamilton, Mark
AU  - Falchi, Alessandra
AU  - Pozo Sanchez, Francisco
AU  - Dunford, Linda
AU  - Cogdale, Jade
AU  - Jansen, Tessa
AU  - Guiomar, Raquel
AU  - Enkirch, Theresa
AU  - Burgui, Cristina
AU  - Sigerson, Debbie
AU  - Blanchon, Thierry
AU  - Martínez Ochoa, Eva María
AU  - Connell, Jeff
AU  - Ellis, Joanna
AU  - van Gageldonk-Lafeber, Rianne
AU  - Kislaya, Irina
AU  - Rose, Angela Mc
AU  - Valenciano, Marta
AU  - I-MOVE-COVID-19 primary care study team
PY  - 2021
DO  - 10.2807/1560-7917.ES.2021.26.29.2100670
UR  - http://hdl.handle.net/20.500.12105/14166
AB  - We measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary care/outpatient level among adults ≥ 65 years old using a multicentre test-negative design in eight European countries. We included 592 SARS-CoV-2...
LA  - eng
PB  - European Centre for Disease Prevention and Control (ECDC)
KW  - COVID-19
KW  - Europe
KW  - SARS-CoV-2
KW  - Multicentre study
KW  - Test-negative design
KW  - Vaccine effectiveness
KW  - COVID-19
KW  - SARS-CoV-2
KW  - Adult
KW  - Aged
KW  - COVID-19 Vaccines
KW  - Europe
KW  - Humans
KW  - Primary Health Care
TI  - Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021
TY  - research article
ER  -